Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Gastric cancer is the third leading cause of cancer-related deaths worldwide. Multidisciplinary team management is essential for all patients with localized gastric cancer.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type.
• 2 Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage.
• 3 Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: